Concepedia

Rachel Borboa

RB

Statistics

Publications

9

Citations

1K

H-Index

9

Active since

2009

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Novartis (Singapore)

Swiss Tropical and Public Health Institute

University of California San Diego

University of Basel

Rachel Borboa is an author at Genomics Institute of the Novartis Research Foundation specializing in pharmacology, antimalarial drug development, and antimalarial agents.

Publications per year

2009–2014

9

Publications

9

Imaging of <i>Plasmodium</i> Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

Stephan Meister, David Plouffe, Kelli Kuhen et al. · Science · 2011 · 347 citations · Full text

, , +16

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

Kelli Kuhen, Arnab K. Chatterjee, Matthias Rottmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 158 citations · Full text

, , +17

Whole-genome sequencing and microarray analysis of ex vivo <i>Plasmodium vivax</i> reveal selective pressure on putative drug resistance genes

Neekesh V. Dharia, A. Taylor Bright, Scott J Westenberger et al. · Proceedings of the National Academy of Sciences · 2010 · 106 citations

, , +17

Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents

Tao Wu, A. S. Nagle, Kelli Kuhen et al. · Journal of Medicinal Chemistry · 2011 · 104 citations · Full text

, , +17

Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents

A. S. Nagle, Tao Wu, Kelli Kuhen et al. · Journal of Medicinal Chemistry · 2012 · 93 citations · Full text

, , +17

1–5 of 9